|
Market Cap (3-Jul) $75,017,136 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (19-Jun) 12,988,365 (0.64%) (278th) |
|
52w High $0.073 |
52w Low $0.026 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 6 February 2023, 11:37. The announcement is not marked as price sensitive, and is 2 page(s) in length and 249.08kb in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 0.216% short sold according to ASIC data. It was ranked the 402nd most shorted stock on the ASX. It is now ranked as the 278th most shorted stock on the ASX with 0.641% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| Follow up to NCCN Guidelines for Breast Cancer ASX Release | 6 February 2023, 11:37 |
| Appendix 4C & Quarterly Activities Report - Dec-22 Qtr | 30 January 2023, 9:53 |
| New Version of NCCN Guidelines for Breast Cancer | 30 January 2023, 9:47 |
| Change of Director's Interest Notice - Mr Richard Valencia | 27 January 2023, 15:01 |
You must be logged in to post a reply.
ImpediMed 